Pfizer Inc
NYSE: PFE
$24.76
-$0.04 (-0.2%)
Real Time Data Delayed 15 Min.
PFE Articles
This week will mark the first crest of earnings season as we have 11 of the 30 DJIA components reporting earnings this week alone. On Tuesday, we have earnings from Caterpillar Inc. (NYSE: CAT),...
Published:
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest...
Published:
Short sellers upped their investments in stocks of the most prominent financial firms. Short interest in Bank of America (BAC), AIG (AIG), Wells Fargo (WFC), and Freddie Mac (FRE) all rose for the...
Published:
Last Updated:
It is hard to say whether a person is better off stopping smoking and lessening their chances of a heart attack or killing themselves. Some of the anti-smoking drugs from Pfizer (PFE) and...
Published:
Last Updated:
Reuters: California declared a financial emergency. Reuters: An SEC attorney raised concern about a Madoff report in 2004. Reuters: Auto parts supplier Lear filed for bankruptcy....
Published:
Last Updated:
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
Published:
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program under the Obama administration and with a Democratic Congress. What is certain...
Published:
Reuters: The heads of the emerging markets, the so-called BRICs, held their first global summit. Reuters: Obama will be tested this week on financial reforms. Reuters: Rich nations are...
Published:
Last Updated:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down...
Published:
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled a...
Published:
Short selling is among the most controversial investment practices and has been blamed for sharp sell-offs in the stocks of a number of large companies, especially financial firms. Governments in...
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual...
Published:
According to Reuters, banks may be hard hit by the bankruptcy of General Growth (GGP) and future commercial real estate defaults. Reuters reports that VW may overtake Toyota (TM) as the No.1 car...
Published:
Last Updated:
According to Reuters, Obama must get Americans to spend now and save later to help the economy, and consumers are wary of spending. Reuters reports that the SEC will consider restricting short...
Published:
Last Updated:
According to The Wall Street Journal, large US companies held their R&D spending steady in the fourth quarter of last year even though in most cases their revenue fell. According to the paper,...
Published:
Last Updated: